Cemiplimab for Basal Cell Carcinoma User Reviews
Brand names: Libtayo
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
Learn more about Basal Cell Carcinoma
Care guides
Symptoms and treatments
More about cemiplimab
- Check interactions
- Compare alternatives
- Reviews (10)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
"I've been on Libtayo since June 2022. Every 3 weeks. It's working very well and the main side effect is the horrible itching just about everywhere. I had BCC very badly. My oncologist said it was the worst case he had ever seen in his career. I was seeing a dermatologist at first and he had me on pill-based chemotherapy (Erivedge, I think) that was horrible, and it did not work after 10 months. I lost 40 lbs and felt like I was dying. As the sores turned into tumors, he gave up and sent me to an oncologist and then I had to have incision surgery to remove the tumors. The BCC had gone onto my skin very deep and was a major concern. The Libtayo was a lifesaver for sure. The schedule is for 2 years of treatment. I'm 18 months into treatment and doing well. I get CT scans every 12 weeks to monitor progress, which the doctor says I'm responding to very well. The itching has been my only problem, and Fexofenadine helps with it."